术后恶心呕吐管理第四版共识指南
该共识由美国加速康复学会和门诊麻醉学会资助的国际专家小组制定,基于截至2019年9月的文献系统综述,为成人和儿童术后恶心呕吐(PONV)提供循证指南。指南涵盖高风险患者识别、基线风险管理、预防选择、补救治疗及PONV方案实施,并关注新型药物和加速康复路径中的管理。
要点
- 推荐基于风险分层进行PONV预防,高危患者考虑多模式预防。
- 新型药物如第二代5-HT3受体拮抗剂、NK1受体拮抗剂和多巴胺拮抗剂有循证推荐。
- 指南强调PONV管理应纳入加速康复路径,并提供机构实施方案。
核心结论
- 国际专家小组基于截至2019年9月的文献系统综述,制定了成人和儿童PONV管理的循证共识指南。
研究设计与样本
- 由美国加速康复学会和门诊麻醉学会资助的国际专家小组制定,基于截至2019年9月的文献系统综述。
主要发现
- 指南提供了高风险患者识别、基线PONV风险管理、预防选择、补救治疗及机构PONV方案实施的推荐。
- 指南聚焦于新型药物(如第二代5-HT3受体拮抗剂、NK1受体拮抗剂、多巴胺拮抗剂)的证据,并讨论了多模式PONV预防及PONV管理作为加速康复路径的一部分。
- 该指南得到23个不同学科专业学会和组织的认可。
关键数值与推荐
- 推荐基于风险分层进行PONV预防,包括识别高风险患者和管理基线风险。
- 推荐考虑新型药物如第二代5-HT3受体拮抗剂、NK1受体拮抗剂和多巴胺拮抗剂用于PONV预防或治疗。
- 推荐在加速康复路径中实施PONV管理,并基于专家共识讨论对所有有风险手术患者实施多模式PONV预防。
临床怎么用
- 围术期从业者应使用本指南进行成人和儿童PONV的风险分层、预防和治疗。
- 在加速康复路径中应整合PONV管理策略,并考虑机构层面实施PONV方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This consensus statement presents a comprehensive and evidence-based set of guidelines for the care of postoperative nausea and vomiting (PONV) in both adult and pediatric populations. The guidelines are established by an international panel of experts under the auspices of the American Society of Enhanced Recovery and Society for Ambulatory Anesthesia based on a comprehensive search and review of literature up to September 2019. The guidelines provide recommendation on identifying high-risk patients, managing baseline PONV risks, choices for prophylaxis, and rescue treatment of PONV as well as recommendations for the institutional implementation of a PONV protocol. In addition, the current guidelines focus on the evidence for newer drugs (eg, second-generation 5-hydroxytryptamine 3 [5-HT3] receptor antagonists, neurokinin 1 (NK1) receptor antagonists, and dopamine antagonists), discussion regarding the use of general multimodal PONV prophylaxis, and PONV management as part of enhanced recovery pathways. This set of guidelines have been endorsed by 23 professional societies and organizations from different disciplines (Appendix 1).Guidelines currently available include the 3 iterations of the consensus guideline we previously published, which was last updated 6 years ago; a guideline published by American Society of Health System Pharmacists in 1999; a brief discussion on PONV management as part of a comprehensive postoperative care guidelines; focused guidelines published by the Society of Obstetricians and Gynecologists of Canada, the Association of Paediatric Anaesthetists of Great Britain & Ireland and the Association of Perianesthesia Nursing; and several guidelines published in other languages.The current guideline was developed to provide perioperative practitioners with a comprehensive and up-to-date, evidence-based guidance on the risk stratification, prevention, and treatment of PONV in both adults and children. The guideline also provides guidance on the management of PONV within enhanced recovery pathways.The previous consensus guideline was published 6 years ago with a literature search updated to October 2011. Several guidelines, which have been published since, are either limited to a specific populations or do not address all aspects of PONV management. The current guideline was developed based on a systematic review of the literature published up through September 2019. This includes recent studies of newer pharmacological agents such as the second-generation 5-hydroxytryptamine 3 (5-HT3) receptor antagonists, a dopamine antagonist, neurokinin 1 (NK1) receptor antagonists as well as several novel combination therapies. In addition, it also contains an evidence-based discussion on the management of PONV in enhanced recovery pathways. We have also discussed the implementation of a general multimodal PONV prophylaxis in all at-risk surgical patients based on the consensus of the expert panel.
引用
- Gan TJ, Belani KG, Bergese S, et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg. 2020. PMID: 32467512. doi:10.1213/ANE.0000000000004833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。